Home » Stocks » APOP

Cellect Biotechnology Ltd. (APOP)

Stock Price: $2.90 USD -0.05 (-1.69%)
Updated Jan 20, 2021 4:00 PM EST - Market closed
After-hours: $2.87 -0.03 (-1.03%) Jan 20, 4:42 PM
Market Cap 12.00M
Revenue (ttm) n/a
Net Income (ttm) -4.80M
Shares Out 212.64M
EPS (ttm) -0.85
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 20
Last Price $2.90
Previous Close $2.95
Change ($) -0.05
Change (%) -1.69%
Day's Open 3.08
Day's Range 2.73 - 3.14
Day's Volume 191,666
52-Week Range 1.24 - 3.95

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 2 months ago

Promising Progress on Clinical D evelopment Progress , Collaboration s and Partnering

GlobeNewsWire - 2 months ago

Tel Aviv, Israel , Oct. 22, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology which enables the functional selection of cells facilitat...

GlobeNewsWire - 3 months ago

Management to Highlight Progress in Bone Marrow Transplant (BMT) and Chimeric Antigen Receptor T Cell (CAR T) Business Collaborations

PRNewsWire - 5 months ago

TEL AVIV, Israel, Aug. 12, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd.

PRNewsWire - 7 months ago

TEL AVIV, Israel, May 21, 2020 /PRNewswire/ -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today repor...

GlobeNewsWire - 7 months ago

TEL AVIV, Israel, May 21, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: "APOP"), a developer of innovative technology which enables the functional selection of stem cells, tod...

GlobeNewsWire - 8 months ago

TEL AVIV, Israel, May 12, 2020 (GLOBE NEWSWIRE) -- Cellect Biotechnology Ltd. (NASDAQ: APOP), a developer of innovative technology which enables the functional selection of stem cells, today...

24/7 Wall Street - 8 months ago

Cellect Biotechnology Ltd. (NASDAQ: APOP) shares nearly doubled to start the week after the company announced progress with its bone marrow transplantation process.

Benzinga - 10 months ago

Shares of thinly-traded nano-cap biotech Cellect Biotechnology Ltd – ADR (NASDAQ: APOP) are advancing strongly Wednesday.

InvestorPlace - 1 year ago

Cellect Biotechnology (APOP) news for Tuesday includes new patent approvals overseas that have APOP stock soaring higher. The post Cellect Biotechnology News: APOP Stock Rockets 76% on New Pat...

Benzinga - 1 year ago

Cellect Biotechnology Ltd – ADR (NASDAQ: APOP) shares are more than doubling following an announcement concerning patents in two regions.

Benzinga - 1 year ago

The thinly traded nano-cap penny stock CELLECT BIOTECH/S ADR (NASDAQ: APOP) was soaring Monday.

About APOP

Cellect Biotechnology, a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. It is developing the ApoTainer selection kit, a shelf stem cell selection kit for allogeneic hematopoietic stem cell transplantation procedures for patients suffering from hematological malignancies. The company has collaborations with the denovoMATRIX group of the Technische Universität Dresden to conduct examinations into th... [Read more...]

Industry
Biotechnology
Founded
2011
CEO
Dr. Shai Yarkoni
Employees
14
Stock Exchange
NASDAQ
Ticker Symbol
APOP
Full Company Profile

Financial Performance

Financial numbers in millions ILS.
Financial Statements